Target intelligence / Profile preview

Lysosomal acidic compartment and autophagy machinery

Molecular classification
Other, Enzyme, Protein complex
01

Overview

The lysosomal acidic compartment and autophagy machinery represent a complex cellular system responsible for the degradation and recycling of cytoplasmic components to maintain proteostasis (Mindell, 2012; Mizushima & Komatsu, 2011). The lysosome maintains an acidic internal environment (pH 4.5–5.0) through the action of vacuolar-type H+-ATPases (V-ATPases), which is essential for the function of over 60 different acid hydrolases (Forgac, 2007). Autophagy is the process that delivers cargo, such as damaged organelles or protein aggregates, to these lysosomes via double-membraned vesicles called autophagosomes (Nixon, 2013). In oncology, this machinery is frequently exploited by tumor cells to survive nutrient deprivation and therapy-induced stress, whereas its dysfunction is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's (Amaravadi et al., 2019; Nixon, 2013). Pharmacological agents like hydroxychloroquine and chloroquine target this system by accumulating in lysosomes and increasing their pH, thereby inhibiting the final stages of autophagic degradation (Mauthe et al., 2018). Other drugs, such as rapamycin, modulate the system by inhibiting mTORC1 to induce autophagy (Mizushima & Komatsu, 2011). Therapeutic challenges include the potential for systemic toxicity and the double-edged sword nature of autophagy, which can be either cytoprotective or cytotoxic depending on the context (Onorati et al., 2018).

Other names
LysosomeAutophagy pathwayMacroautophagy machineryLysosomal-autophagy systemVacuolar-type H+-ATPase regulated compartment
02

Mechanism of action

Modulation of lysosomal pH, inhibition of V-ATPase proton pumps, or inhibition of ATG-mediated autophagosome formation to alter cellular degradative flux.

03

Biological functions

Protein degradationCellular homeostasisNutrient recyclingOrganelle turnoverStress response
04

Disease associations

CancerNeurodegenerative diseaseLysosomal storage diseaseInfectionInflammation
05

Safety considerations

RetinopathyCardiotoxicity (QT prolongation)Neuromuscular toxicityImpaired immune responseSystemic toxicity due to broad inhibition of cellular degradation
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

LC3-II/LC3-I ratiop62 (SQSTM1) protein levelsCathepsin B/D activityLysotracker stainingLysosomal pH

Beyond the preview

Go deeper on Lysosomal acidic compartment and autophagy machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal acidic compartment and autophagy machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call